Diagnostic hapten-carrier conjugates BSA-aldosterone (RAA/Aldo), OVA-aldosterone (RAA/Aldo), KLH-aldosterone (RAA/Aldo) for HypertensionRAA/Aldodetection in Competitive immunoassay validation (Competitive ELISA), Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Product Details
Aldosterone is the main mineralocorticoid steroid hormone produced by the zona glomerulosa of the adrenal cortex in the adrenal gland. It is essential for sodium conservation in the kidney, salivary glands, sweat glands, and colon. It plays a central role in the homeostatic regulation of blood pressure, plasma sodium (Na+), and potassium (K+) levels.Genemedi produces core diagnostic ingredients for test of Hypertension and related syndrome.
GeneMedi offers Diagnostic hapten-carrier conjugates BSA-aldosterone (RAA/Aldo), OVA-aldosterone (RAA/Aldo), KLH-aldosterone (RAA/Aldo) for Hypertension RAA/Aldo detection in Competitive immunoassay validation (Competitive ELISA), Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Hypertension test are suitable for in functional ELISA, and other immunoassays in dignostics.
Product Description
Cat No.
|
GMP-SMT-RAA-Aldo-Ag-Ab
|
Product Name
|
BSA-aldosterone (RAA/Aldo) / OVA-aldosterone (RAA/Aldo)
|
Expression platform
|
Synthetic
|
Bioactivity validation
|
aldosterone (RAA/Aldo) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in RAA/Aldo level test of Cardiovascular disease (Hypertension, blood pressure, hyperaldosteronism, renal artery stenosis (narrowing of
the renal artery), congestive heart failure, cirrhosis, some kidney diseases
(e.g., nephrotic syndrome).) and related syndrome evaluation
|
Products description
|
Competitive immunoassay-validated hapten-carrier conjugates BSA-aldosterone (RAA/Aldo) / OVA-aldosterone (RAA/Aldo) is Synthetic.
|
Purity
|
|
Application
|
Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
|
Formulation
|
Lyophilized from sterile PBS, PH 7.4
|
Storage
|
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
|
Cat No.
|
GMP-SMT-RAA-Aldo-Ag-Ab
|
Product Name
|
Anti-human aldosterone (RAA/Aldo) mouse monoclonal antibody (mAb)
|
Expression platform
|
Hybridoma
|
Isotypes
|
Mouse IgG
|
Bioactivity validation
|
aldosterone (RAA/Aldo) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other aldosterone (RAA/Aldo) antibodies in RAA/Aldo level test of Cardiovascular disease (Hypertension, blood pressure, hyperaldosteronism, renal artery stenosis (narrowing of
the renal artery), congestive heart failure, cirrhosis, some kidney diseases
(e.g., nephrotic syndrome).) and related syndrome evaluation.
|
Tag
|
mFc
|
Products description
|
Anti-human aldosterone (RAA/Aldo) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
|
Specics
|
mouse
|
Purity
|
Purity: ≥95% (SDS-PAGE)
|
Application
|
Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
|
Formulation
|
Lyophilized from sterile PBS, PH 7.4
|
Storage
|
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
|
Diagnostic antibodies and antigens for Epilepsy-related valproate (VPA) toxicity testing: Sodium valproate (VPA)
Valproate is a commonly used antiepileptic drug for the treatment of epilepsy and seizures. It is safe for use in both adults and children more than three years of age. Valproate toxicity can occur both accidentally and intentionally. Acute valproate overdose usually presents with CNS depression/encephalopathy, electrolyte abnormalities such as hypernatremia, elevated transaminase levels, hyperammonemia, and hepatoxicity. In patients with a severe overdose of valproate, patients can present with hypotension, tachycardia, respiratory depression, metabolic acidosis, cerebral edema, and valproate-related hyperammonemic encephalopathy which may progress to coma and death. GENEMEDI developed the Gastrin-17 (G-17) antigens and antibodies for the diagnosis of valproate toxicity based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.